Open AccessBalancing Cancer Risk and Efficacy of Using Cyclophosphamide to Treat Idiopathic Membranous Nephropathy
Author(s) -
Sana Khan,
W. Kline Bolton
Publication year - 2014
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.04130414
Subject(s) - medicine , cyclophosphamide , membranous nephropathy , cancer , nephropathy , oncology , intensive care medicine , chemotherapy , glomerulonephritis , kidney , diabetes mellitus , endocrinology
In 1950, Coons and Kaplan described a technique for labeling antibodies with fluorescent probes to detect antigens in tissue ([1][1]). Using this technique, it was possible to classify glomerulopathies according to their appearance by immunofluorescence staining. One distinct entity, membranous
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom